GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Net Cash Flow came in at -$1.8 million in Q4 2025, down 796.23% YoY from $261720.6 in Q4 2024, and down 184.0% on a QoQ basis from $2.2 million in Q3 2025.
GridAI Technologies (GRDX) Net Cash Flow (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Net Cash Flow data on file, last reported at -$1.8 million in Q4 2025.
- Quarterly Net Cash Flow fell 796.23% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $173614.0 (up 104.89% YoY) and the FY2025 annual result came in at $510041.0, up 114.37% from the prior year.
- Net Cash Flow declined to -$1.8 million in Q4 2025, from $2.2 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $6.0 million in Q1 2021 to a low of -$4.5 million in Q2 2022.
- A 5-year average of -$248728.9 and a median of -$160975.5 in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow soared 1451.13% — and 2025, when it sank 796.23%.
- Tracing GRDX's Net Cash Flow over 5 years: stood at $962029.0 in 2021, then sank by 107.07% to -$68050.0 in 2022, then soared by 1451.13% to $919444.0 in 2023, then sank by 122.11% to -$203316.0 in 2024, then plunged by 796.23% to -$1.8 million in 2025.
- The last three Net Cash Flow figures came in at -$1.8 million (Q4 2025), $2.2 million (Q3 2025), and -$54878.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 225.59 Mn |
| 10 | GridAI Technologies | 6.37 Mn | 6.37 Mn | - | -1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.82 Mn |
| Dec 31, 2025 | -1.82 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -54,878.00 |
| Jun 30, 2025 | -54,878.00 |
| Mar 31, 2025 | -118,635.00 |
| Mar 31, 2025 | -118,635.00 |
| Dec 31, 2024 | -203,316.00 |
| Dec 31, 2024 | -203,316.00 |
| Sep 30, 2024 | -295,687.00 |
| Sep 30, 2024 | -295,687.00 |
| Jun 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | -279,857.00 |
| Mar 31, 2024 | -279,857.00 |
| Dec 31, 2023 | 919,444.00 |
| Dec 31, 2023 | 919,444.00 |
| Sep 30, 2023 | 2.06 Mn |
| Sep 30, 2023 | 2.06 Mn |